Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Canadian Cancer Trials Group
National Cancer Institute (NCI)
University of Michigan Rogel Cancer Center
NRG Oncology
Alliance for Clinical Trials in Oncology
Emory University
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Tempus AI
Canadian Cancer Trials Group
Clinica Universidad de Navarra, Universidad de Navarra
MultiCare Health System Research Institute
Children's Oncology Group
Fudan University
Children's Oncology Group
University of Illinois at Chicago
Centre Paul Strauss
Baptist Health South Florida
University of Erlangen-Nürnberg Medical School
Ohio State University Comprehensive Cancer Center
National Taiwan University Hospital
Fudan University
Mayo Clinic
Shanghai Tongji Hospital, Tongji University School of Medicine
Tempus AI
SWOG Cancer Research Network
University of Michigan Rogel Cancer Center
The University of Hong Kong-Shenzhen Hospital
Ankara Etlik City Hospital
Mayo Clinic
Fudan University
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
NRG Oncology
Replimune Inc.
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Mayo Clinic
Herlev Hospital
Technische Universität Dresden
Herlev Hospital
M.D. Anderson Cancer Center
Mayo Clinic
SWOG Cancer Research Network
University Hospital, Lille
University of Pittsburgh
European Organisation for Research and Treatment of Cancer - EORTC
Mayo Clinic
Intergruppo Melanoma Italiano
IFOM ETS - The AIRC Institute of Molecular Oncology
IFOM ETS - The AIRC Institute of Molecular Oncology
Erasmus Medical Center